CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ascendis Health Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ascendis Health Ltd
1 Carey Street, Wynberg
Phone: +27 110369600p:+27 110369600 SANDTON, 2090  South Africa Ticker: ASCASC
Business Summary
Ascendis Health Limited is a South Africa-based health and wellness investment holding company. The Company mainly focuses on supplying pharmaceutical and animal health products, as well as clinical and diagnostic medical devices. The Company operates through four segments: Consumer Health, Pharma, Medical Devices, and Animal Health. Its Consumer Health segment is focused on skin and body, over the counter, complementary, and alternative consumer products. Its Pharma segment incorporates Ascendi's pharmaceutical products. Its Medical Devices incorporates the supply of medical devices and consumables. Its Animal Health incorporates manufacturing and distribution of animal health products. Its brands include Bettaway, Chela-Fer, Mg Chela Mag, Cheg-Preg, JungleVites, MenaCal7, Solal, Reuterina, Sinucon, Clonam, Phlexy, Surgical Innovations, RCA, The Scientific Group, Pharmachem and Vitaforce.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20236/30/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2844 Perfumes, cosmetics, and other toilet preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Non-Executive Independent Chairman of the Board BhartiHarie 12/9/2022
Acting Chief Executive Officer and Chief Transition Officer, Executive Director CarlNeethling 9/14/2022 5/11/2022
Chief Operating Officer RiyasFadal 47 5/1/2022 5/1/2022
6 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Kyron Laboratoires (Pty) Ltd. 29 Barney Road Johannesburg Benrose South Africa

Business Names
Business Name
ASC
Kyron Laboratoires (Pty) Ltd.
Remedica Holdings Limited
Scitec International Societe A Responsabilite Limitee

General Information
Number of Employees: 3,200 (As of 6/30/2021)
Outstanding Shares: 633,784,508 (As of 12/31/2023)
Shareholders: 17,016
Stock Exchange: JNB
Fax Number: +27 110369602


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Thursday, April 25, 2024